This study shows that nucleotides, as well as ions, regulate the opiate receptors of brain. GMP-P(NH)P and Na+ reduce the amount of steady-state specific [3H]dihydromorphine binding and increase the rate of dissociation of the ligand from the opiate receptor. In contrast, Mn2+ decreases the rate of ligand dissociation and antagonizes the ability of Na+ to increase dissociation. The effects of GMP-P(NH)P on steady-state binding and dissociation are not reversed by washing. Only GTP, GDP, ITP, and IMP-P(NH)P, in addition to GMP-P(NH)P, increase the rate of dihydromorphine dissociation. The site of nucleotide action appears to have high affinity: <1 &M GMP-P(NH)P produces half-maximal increases in ligand dissociation. GMP-P(NH)P-and Na+-directed increases in dissociation have also been (2) have in fact suggested that tolerance to opiates in human beings and animals is a result of regulation of adenylate cyclase by opiates. As part of the search for some evidence for a "coupling" between the opiate receptors of brain and its adenylate cyclase, I have investigated the effects of nucleotides on opiate binding to rat brain membranes. These studies were initiated since it is known that glucagon (4-6), prostaglandin E1 (7), and ,B-adrenergic (8, 9) receptors, which regulate adenylate cyclases, are all regulated themselves by nucleotides. For these three classes of agonists, agonist occupation of its receptor in the presence of guanine nucleotide (10-12) leads to increased adenylate cyclase activity, yet the presence of guanine nucleotides selectively decreases agonist but not antagonist affinity and increases agonist dissociation from the receptor. In addition, the occupation of the prostaglandin E1 and f,-adrenergic receptors by only agonists for extended periods of time leads to a condition (termed "desensitization") in which agonist no longer can activate the adenylate cyclase complex* to the same extent as they did before the long-term exposure to the agonist (7, 9, 13, 14) . Lefkowitz and coworkers (7, 9) ) was from New England Nuclear, Boston, MA. Naloxone-HCI was obtained from Endo Labs., Garden City, NY; levallorphan was a gift from Hoffman-La Roche Inc., Nutley, NJ. The nucleotides, GMP-P(NH)P, AMP-P(NH)P, CMP-P(NH)P, UMP-P(NH)P, and IMP-P(NH)P, were purchased from ICN Pharmaceuticals, Irvine, CA. All other nucleotides were obtained from Sigma Chemical Co., St. Louis, MO.
have in fact suggested that tolerance to opiates in human beings and animals is a result of regulation of adenylate cyclase by opiates. As part of the search for some evidence for a "coupling" between the opiate receptors of brain and its adenylate cyclase, I have investigated the effects of nucleotides on opiate binding to rat brain membranes. These studies were initiated since it is known that glucagon (4-6), prostaglandin E1 (7), and ,B-adrenergic (8, 9) receptors, which regulate adenylate cyclases, are all regulated themselves by nucleotides. For these three classes of agonists, agonist occupation of its receptor in the presence of guanine nucleotide (10) (11) (12) leads to increased adenylate cyclase activity, yet the presence of guanine nucleotides selectively decreases agonist but not antagonist affinity and increases agonist dissociation from the receptor. In addition, the occupation of the prostaglandin E1 and f,-adrenergic receptors by only agonists for extended periods of time leads to a condition (termed "desensitization") in which agonist no longer can activate the adenylate cyclase complex* to the same extent as they did before the long-term exposure to the agonist (7, 9, 13, 14) . Lefkowitz and coworkers (7, 9) have recently suggested that this desensitization phenomenon is a result of an alteration in the agonist-receptor-adenylate cyclase complex which can be reversed by guanine nucleotides.
The data presented in ) was from New England Nuclear, Boston, MA. Naloxone-HCI was obtained from Endo Labs., Garden City, NY; levallorphan was a gift from Hoffman-La Roche Inc., Nutley, NJ. The nucleotides, GMP-P(NH)P, AMP-P(NH)P, CMP-P(NH)P, UMP-P(NH)P, and IMP-P(NH)P, were purchased from ICN Pharmaceuticals, Irvine, CA. All other nucleotides were obtained from Sigma Chemical Co., St. Louis, MO.
Male Wistar rats (Marland Farms, Hewitt, NJ) weighing 250-50 g were decapitated and their brains were rapidly removed. The cerebellums were then excised, and the remainder was placed in 10 volumes of iced 50 mM Tris-HCl, pH 7.4, and homogenized (twice for 10 sec) in a Brinkman Polytron at 40. The homogenates were then centrifuged at 27,000 X g for 30 min at 40; the resulting pellet was washed twice with buffer and finally suspended in 50 mM TrissHCI, pH 7.4, (2-5 mg of protein per ml). This preparation (referred to as the "Triswashed" membranes) was made 25 mM NaCl, incubated at 370 for 30 min, and centrifuged at 27,000 X g; the pellet was washed twice at 40 with 50 mM Tris-HCl, pH 7.4. These pellets were then suspended in 50 mM Tris-HCI, pH 7.4, (2-5 mg protein per ml) and are referred to as "Na+-washed" membranes. Membrane preparations were frozen and stored under N2 until they were used. and 163 fmol/mg of protein, respectively. 0, No additions; ,, MnCl2; 0, NaCl; *, GMP-P(NH)P; *, NaCl and GMP-P(NH)P; v, MnCl2 and NaCl.
The presence of two different [3Hjdihydromorphine binding sites in rat brain membranes is further supported by the observation of the biphasic nature of the dissociation of bound dihydromorphine (Fig. 2) . After a 20-min incubation in Tris buffer, although the major amount of the bound [8H]dihydromorphine dissociates slowly with a t1/2 of 4.5 min, a significant amount (<40%) can be seen to dissociate faster with a t 1/2 of <1 min. GMP-P(NH)P and Na+ (and Mn2+ as well) influence the dissociation of dihydromorphine in a complex manner. Both GMP-P(NH)P and Na+ added separately cause the major portion (>60%) of the bound dihydromorphine to dissociate rapidly now with a t1/2 of <0.2 min. The remaining dihydromorphine still dissociates with a slower t 1/2 of 4-5 mi. As already seen with steady-state binding, GMP-P(NH)P and Na+ produce a larger effect on dissociation when added together than when added separately. In the presence of both GMP-P(NH)P and Na+, almost all (285%) of the bound dihydromorphine is converted into a form that dissociates very rapidly with a t1/2 of <0.2 min. The effects of Mn2+ on dihydromorphine dissociation are opposite to those produced by Na+ or GMP-P(NH)P. In the presence of 1 mM Mn2+, although dissociation is still biphasic, most of the bound dihydromorphine (i.e., 2 70%) now dissociates with the very slow t1/2 of 30 min. The remaining amount of dihydromorphine dissociates with a t 1/2 of 4 min and no dihydromorphine dissociates rapidly with a t1/2 Of <1 min.
The potency of GMP-P(NH)P to increase the dissociation of [3H]dihydromorphine was investigated; a concentration of between 0.7 and 1 MM appears to produce a half-maximal increase in the dissociation of dihydromorphine (Fig. 3) . A test of the specificity of the nucleotide effect indicates that at 50 ,MM the only ones that increase [3H]dihydromorphine dissociation besides GMP-P(NH)P are GTP, GDP, ITP, and IMP-P(NH)P (Table 1) . None of the adenine nucleotides, be they mono-, di-, or triphosphates or even AMP-P(NH)P, influence dihydromorphine dissociation. GMP is also without effect. Therefore, although not identical, the specificity and affinity 10 of the nucleotide site in rat brain membranes that influence dihydromorphine binding resembles that which hars been described for the guanine nucleotide site in plasma membranes that regulate the activity of adenylate cyclase (10, 15) .-If these two nucleotide sites are the same or closely related, GMP-P(NH)P would be expected to produce an "irreversible" effe~ct on the specific binding of dihydromorphine, since GMP-P(NH)P produces an "irreversible" activation of adenylate cyclase (15) . When the opiate receptors in rat brain membranes incubated at 32°for 30 min with Mn2+ are compared with those treated with GMP-P(NH)P and Mn +, the GMP P(NH)P-treated membranes exhibit only half as much specific binding of [3H]dihydromorphine as seen with the membranes that have not been treated with GMP-P(NH)P when both are assayed in Tris buffer after extensive washing (Table 2 ). This conditions by the presence of GMP-P(NH)P (see Fig. 1 ).
Dissociation of dihydromorphine from these Mn2+-treated t membranes (Table 2 and Fig. 4 ) resembles that previously shown ( Fig. 2A) for membranes that had not been treated with Mn2+. Both are biphasic: the major component dissociates with s a t1/2 of 4.5 min and the minor component dissociates with a t1/2 of <0.3 min. GMP-P(NH)P addition increases to about 50% that amount dissociating rapidly (i.e., t1/2 < 0.3 min) and the copresence of Na+ and GMP-P(NH)P also induces the remaining 50% to dissociate faster. In contrast, there is only one dissociation component observable from the membranes treated with Mn2+ plus GMP-P(NH)P. In Tris buffer, dissociation occurs slowly with a t1/2 of 4.5 min and when Na+ is added, dissociation occurs with the faster t1/2 of 1.4 min. From these experiments, it appears that after GMP-P(NH)P treatment [3H]dihydromorphine binding to approximately half of the membrane receptor sites is "irreversibly" prevented. Additionally, these "lost" sites seem to correspond to those in control membranes from which dihydromorphine dissociates rapidly (i.e., with a t1/2 of <0.3 min) when either Na+ or GMP-P(NH)P or both are added. Those sites remaining after GMP-P(NH)P treatment are still affected by Na+ (an increase in the rate of dissociations and Mn2+ (a slowing of the dissociation rate).
Therefore, the above data do indicate that the action of GMP-P(NH)P with its nucleotide site leads to an "irreversible" alteration in dihydromorphine binding sites. In order to investigate the general nature of these nucleotide and ion effects on the opiate receptor, dissociation of three other opiate agonists (ie., etorphine, Leu-enkephalin, and Metenkephalin) and the opiate antagonist, naltrexone, have also been examined (Table 3) . Although [3H]etorphine dissociates much more slowly than [3H]dihydromorphine, etorphine dissociation is slowed by Mn2 , sped up by Na+ or GMP-P(NH)P, and greater when both Na+ and GMP-P(NH)P are present than when either is present alone. The two peptide opiate agonists, Leu-and Met-enkephalin, are also induced to dissociate faster (0), with 10MuM GMP-P(NH)P (a), and with 25 mM NaCl and GMP-P(NH)P (v). For membranes treated with Mih2+ plus GMP-P(NH)P: dissociation with no additions (A), with 25 mM NaCI (v), and with 1 mM MnCl2 (-).
by Na+ or GMP-P(NH)P. In contrast to the reaction see with etorphine and dihydromorphine, Na+ appears more potent than GMP-P(NH)P with these peptide opiates and no extra effect over that seen with only Na+ is noticed when both GMP-P(NH)P and Na+ are present. What is also clear from the data in Table 3 is that dissociation of the opiate antagonist, naltrexone, is regulated much like that of the agonists dihydromorphine and etorphine. A detailed illustration of the dissociation of [3H]naltrexone is given in Fig. 2B . GMP-P(NH)P speeds up naltrexone dissociation, as does Na+. GMP-P(NH)P appears to be the more potent of the two and together with Na+ produces the largest increase in naltrexone dissociation (which is 34 times faster than in controls). In addition, Mn2+ slows the dissociation of naltrexone and antagonizes the effects of Na+. Under all these conditions the dissociation of naltrexone is always monophasic with either Na+-or Tris-washed membranes. This is not the case for dihydromorphine (see Figs. 2 and 3 (16) (17) (18) (19) (20) . These data had led to the hypothesis that Na+ ions induce an opiate receptor conformation favorable to antagonist binding and Mn2+ ions induce one favorable to an agonist binding. This paper shows that as little as 50,uM GMP-P(NH)P decreases by half the specific binding of [3H]dihydromorphine. Sodium has a similar affect when tested at 25 mM. The effects of GMP-P(NH)P are like those of Na+, and appear to be on both the affinity and number of dihydromorphine binding sites. As reported by others (21, 22) The effects of GMP-P(NH)P and Na+ on dissociation were similar. Although complex in nature, in general both GMP-P(NH)P and Na+ increase, in a population of previously formed receptor-dihydromorphine complexes, the percentage that dissociates rapidly. However, both increases in the amount of dihydromorphine dissociating rapidly and the actual rate of dihydromorphine dissociation have been observed. Although the increases in dihydromorphine dissociation and decreases in steady-state binding produced by both Na+ and GMP-P(NH)P are in gross agreement, additional information is needed on association rates before a complete understanding of the effects of GMP-P(NH)P The activity of plasma membrane adenylate cyclase is also regulated by a membrane component that binds guanine nucleotides with high affinity and selectivity (10) . The following observations have been made for this site: (a) GTP, GMP-P(NH)P, and GDP are bound with the best affinity; GMP and adenine nucleotides are bound with little affinity or not at all (10) . (b) Whereas GTP and GMP-P(NH)P activate the enzyme, GDP does not but instead blocks activation of the enzyme by GMP-P(NH)P (23); (c) ITP and IMP-P(NH)P are in some instances able to activate the enzyme and in others not able to do so (24) (25) (26) . (d) Activation of adenylate cyclase by GMP-P(NH)P is not readily reversed by washing (15) . The following observations have-been made for the nucleotide site regulating opiate receptors: (a) The amount of GMP-P(NH)P required to halfmaximally increase dihydromorphine dissociation is < 1 uM.
(b) GDP as well as GTP, ITP, and IMP-P(NH)P, all at 50,gM, are equally able to replace GMP-P(NH)P. (c) The effects of GMP-P(NH)P on steady-state binding and dissociation are not reversed by extensive washing. Therefore, although similar, there are differences between the nucleotide site associated with adenylate cyclases and that associated with opiate receptors. Further data are needed to determine the position in the plasma membrane (i.e., inner or outer surface) of these two sites, whether these two sites are in fact related in some manner, and whether or not opiates can influence adenylate cyclase through these nucleotide sites.
Regardless of the final answers to the above questions, it is important to note that there is also a guanine nucleotide site on the plasma membrane that regulates the plasma membrane receptors for at least three known activators of adenylate cyclase. Glucagon, prostaglandin E1, and fl-adrenergic agonists all dissociate faster and have higher Kd values when GMP-P(NH)P is present (4) (5) (6) (7) (8) (9) . Nucleotide control of the opiate receptor is, however, different in at least two ways from its control over these other receptors: (a) with only the opiate receptor, it is possible to observe nucleotide regulation of receptor-antagonist interaction; and (b) GMP-P(NH)P alteration of the glucagon receptor is reversible (27) but that of the opiate receptor appears to be irreversible.
As proposed for the fl-adrenergic and prostaglandin E1 receptors (7-9, 11), only agonist interaction is sensitive to nucleotide regulation because only agonists can induce a "coupling" between receptor and the guanine nucleotide component associated with the adenylate cyclases. The unique sensitivity of the opiate receptor to nucleotide control over antagonist interaction could indicate that the brain's opiate receptors have already been "coupled" due to the presence of endogenous opiate agonists or, instead, due to the basic difference between the two nucleotide binding sites involved. I have recently discovered that nucleotides also regulate the opiate receptors of the neuroblastoma X glioma hybrid NG108-15 cell (unpublished observations), and in these cells opiates inhibit adenylate cyclase (1) (2) (3) 
